Skip to content

A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels

A Clinical Trial to Assess the Effects of a Vitamin Shot on Energy Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06019858
Enrollment
30
Registered
2023-08-31
Start date
2023-06-21
Completion date
2023-07-20
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition, Energy, Fatigue, Mood, Weight Loss

Brief summary

This is a virtual, single-arm clinical trial that will last 30 days. Participants will drink 1 bottle of the Vitamin Energy® shot daily and complete questionnaires at baseline, Day 7, Day 14, and Day 30. Participants' energy, mood, and cognitive function will be evaluated at baseline and at each check-in. Bodyweight will also be assessed at baseline and Day 30. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Interventions

OTHERVitamin Energy Shot

Vitamin Energy® shot is a naturally-caffeinated functional energy shot that contains: Vitamin B3 Vitamin B6 Vitamin B12 Natural Caffeine (green tea extract) L-Carnitine Tartrate Potassium Sorbate Taurine Sucralose

Sponsors

Citruslabs
CollaboratorINDUSTRY
Vitamin Energy®
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Men and women 18 years and over Self-reported issues with: * Energy * Focus * Brain fog Participants who often feel fatigued Willing to maintain the same caffeine consumption during the study period Generally healthy - don't live with any uncontrolled chronic disease

Exclusion criteria

Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. Anyone with known severe allergic reactions. Women who are pregnant, breastfeeding, or attempting to become pregnant Unwilling to follow the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Change in energy levels. [Baseline to Day 30]30 daysSurvey-based assessment (0-5 scale) of participant reported energy levels.

Secondary

MeasureTime frameDescription
Change in ability to concentration. [Baseline to Day 30]30 daysSurvey-based assessment (0-5 scale) of participant reported concentration abilities.
Change in participant-perceived productivity. [Baseline to Day 30]30 daysSurvey-based assessment (0-5 scale) of participants perception of their productivity during the day.
Changes in mood. [Baseline to Day 30]30 daysSurvey-based assessment (0-5 scale) of mood.
Changes in brain fog. [Baseline to Day 30]30 daysSurvey-based assessment (0-5 scale) of brain fog experienced by participants.
Change in body weight. [Baseline to Day 30]30 daysParticipants will weight themselves at baseline and endline and provide their body weight.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026